New Products

CINCINNATI — Procter & Gamble on Tuesday launched Clearblue Advanced Digital Ovulation Test, the only ovulation test that can identify a woman’s four best days to get pregnant, two more days than any other test on the market, according to the company. And in support of the launch, former Dallas Cowboys cheerleader and veteran of ABC's "Dancing with the Stars" Melissa Rycroft will serve as spokeswoman. 

SAN DIEGO — Bumble Bee Foods has introduced three new additions to its gourmet-style Prime Fillet line.

The new Prime Fillet gourmet flavors are available in three varieties: chipotle and olive oil, sundried tomatoes and olive oil, and jalapenos and olive oil. Each of the gourmet flavors contains albacore tuna in olive oil with chopped chipotles, sundried tomatoes or jalapenos and carefully paired seasonings.

NORTH WALES, Pa. — Teva Pharmaceutical Industries has launched a generic opioid medication for treating pain, the company said.

Teva announced the introduction of oxymorphone hydrochloride tablets.

The drug is a generic version of Endo Pharmaceuticals' Opana and will be available in the 5 mg and 10 mg strengths in bottles of 100 tablets.

CINCINNATI — Procter & Gamble has introduced a new lineup of scented bar soaps to its collection of male grooming products. Arriving in stores this month, new Old Spice bar soap is available in the Fiji, Pure Sport and Swagger scents.

AMSTERDAM, N.Y. — Beech-Nut Nutrition and Goya Foods have made a deal to produce baby foods for Hispanic families, Beech-Nut announced.

"One-fourth of all births in America today are to Hispanics, so that any company hoping to grow their business must take their needs and tastes into account," Beech-Nut president Jeff Boutelle said.

PARSIPPANY, N.J. — In recognition of National Park Week April 20 to 28, Reckitt Benckiser's Air Wick is launching a new line of air fresheners inspired by the essence of America's national parks. Proceeds will help benefit the National Parks Foundation.

NEW YORK — An experimental drug developed by AstraZeneca for rheumatoid arthritis produced mixed results in measurements of patients' conditions, according to results of a late-stage clinical trial.

AstraZeneca announced initial results of the phase-3 "OSKIRA-1" trial of fostamatinib, which it calls the first oral spleen tyrosine kinase inhibitor in development for RA.

PARSIPPANY, N.J. — Actavis will market and distribute an authorized generic version of a genital herpes ointment made by Valeant Pharmaceuticals International, the companies said Friday.

The agreement centers around Zovirax, known generically as acyclovir, in the 5% strength. The Food and Drug Administration approved the generic version, made by Mylan, on Wednesday. Financial terms of the deal were not disclosed.